日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models.

内源性 CD28 驱动 CAR T 细胞在骨髓瘤和淋巴瘤模型中的持续活性。

Lieberman Mackenzie M, Tong Jason H, Odukwe Nkechi U, Chavel Colin A, Bishara Gina G, Crasti Kimberly M, Herr Megan M, Goala Payal, Purdon Terence J, Burchett Rebecca, Gillard Bryan M, Brackett Craig M, Tario Joseph D, Rosario Spencer R, McGray Aj Robert, Bramson Jonathan L, Davila Marco L, Brentjens Renier J, Malek Ehsan, Lee Kelvin P, Olejniczak Scott H

Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival

自体造血干细胞移植和来那度胺维持治疗1年后多发性骨髓瘤的微小残留病灶状态与长期总生存期相关

Pasquini, Marcelo C; Wallace, Paul K; Logan, Brent; Kaur, Manmeet; Tario, Joseph D; Howard, Alan; Zhang, Yali; Brunstein, Claudio; Efebera, Yvonne; Geller, Nancy; Giralt, Sergio; Hari, Parameswaran; Horowitz, Mary M; Koreth, John; Krishnan, Amrita; Landau, Heather; Somlo, George; Shah, Nina; Stadtmauer, Edward; Vogl, Dan T; Vesole, David H; McCarthy, Philip L; Hahn, Theresa

Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors

根据受者和供者的免疫特征分析人类白细胞抗原匹配的亲缘供者和单倍体相合异基因造血干细胞移植受者的预后

Herr, Megan M; Balderman, Sophia R; Wallace, Paul K; Zhang, Yali; Tario, Joseph D Jr; Buxbaum, Nataliya P; Holtan, Shernan; Ross, Maureen; McCarthy, Philip L; Betts, Brian; Maslak, Peter; Hahn, Theresa E

Short-Term Storage of Mobilized Peripheral Blood Stem Cells in a Closed System Changes the Microenvironment and May Affect the Quantity of CD34+ and CD34+CD38-CD45RA-CD90+ Cells

在封闭系统中短期储存动员的外周血干细胞会改变微环境,并可能影响 CD34+ 和 CD34+CD38-CD45RA-CD90+ 细胞的数量。

Amro Elshoury ,Orla Maguire ,Alexis Conway ,Joseph Tario ,Kah Teong Soh ,Maureen Ross ,Theresa Hahn ,Joanne Becker ,Paul Wallace ,Philip L McCarthy ,Hans Minderman ,George L Chen

Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma

在单细胞分辨率下解读多发性骨髓瘤中的空间基因组异质性

Maximilian Merz #, Almuth Maria Anni Merz #, Jie Wang #, Lei Wei #, Qiang Hu, Nicholas Hutson, Cherie Rondeau, Kimberly Celotto, Ahmed Belal, Ronald Alberico, AnneMarie W Block, Hemn Mohammadpour, Paul K Wallace, Joseph Tario, Jesse Luce, Sean T Glenn, Prashant Singh, Megan M Herr, Theresa Hahn, Meh

Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study

奥法妥木单抗联合HyperCVAD/HD-MA诱导治疗可使新诊断的套细胞淋巴瘤患者达到较高的微小残留病灶阴性率:一项II期研究的结果

Torka, Pallawi; Akhtar, Othman S; Reddy, Nishitha M; Baysal, Bora E; Kader, Angela; Groman, Adrienne; Nichols, Jenna; Mavis, Cory; Tario, Joseph D; Block, AnneMarie W; Sait, Sheila N J; Ghione, Paola; Sundaram, Suchitra; Przespolewski, Eugene R; Mohr, Alice; Lund, Ian; Kostrewa, Jessica; McWhite, Kenneth; DeMarco, Joseph; Johnson, Michael; Darrall, Andrea; Thomas-Talley, Rosh-Neke; Wallace, Paul K; Neppalli, Vishala; Hutson, Alan; Hernandez-Ilizaliturri, Francisco J

Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

普萘洛尔联合帕博利珠单抗治疗局部晚期和转移性黑色素瘤的I期临床试验:安全性、耐受性和初步抗肿瘤活性证据

Gandhi, Shipra; Pandey, Manu R; Attwood, Kristopher; Ji, Wenyan; Witkiewicz, Agnieszka K; Knudsen, Erik S; Allen, Cheryl; Tario, Joseph D; Wallace, Paul K; Cedeno, Carlos D; Levis, Maria; Stack, Suzanne; Funchain, Pauline; Drabick, Joseph J; Bucsek, Mark J; Puzanov, Igor; Mohammadpour, Hemn; Repasky, Elizabeth A; Ernstoff, Marc S

Circulating CD14+ HLA-DRlo/- monocytic cells as a biomarker for epithelial ovarian cancer progression

循环 CD14+ HLA-DRlo/- 单核细胞作为上皮性卵巢癌进展的生物标志物

Ashley E Stenzel, Scott I Abrams, Janine M Joseph, Ellen L Goode, Joseph D Tario Jr, Paul K Wallace, Divjot Kaur, Anna-Kay Adamson, Matthew F Buas, Amit A Lugade, Angela Laslavic, Sarah E Taylor, Brian Orr, Robert P Edwards, Esther Elishaev, Kunle Odunsi, Jennifer M Mongiovi, John Lewis Etter, Stace

CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab

CD319 (SLAMF7) 是在达雷妥尤单抗或埃罗妥珠单抗存在下检测浆细胞的替代标志物

Kah Teong Soh ,Joseph D Tario Jr ,Theresa Hahn ,Jens Hillengass ,Philip L McCarthy ,Paul K Wallace

Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils

癌症早期髓系抑制细胞的量化需要排除嗜碱性粒细胞

Anm Nazmul H Khan, Tiffany R Emmons, Jerry T Wong, Emad Alqassim, Kelly L Singel, Jaron Mark, Brandon E Smith, Joseph D Tario, Kevin H Eng, Kirsten B Moysich, Kunle Odunsi, Scott I Abrams, Brahm H Segal